Bacil Pharma Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 524516

Shareholding pattern / Ownership

Shareholding summary

Dec 2025
  • Promoter0.08%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 0.08% in Dec 2025 qtr

All shareholding details →

Shareholding Trend (Promoter/FII/DII %, real filed periods only)

HolderDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Latest change
Promoter 0.08%0.08%0.20%0.20%10.60%20.70%42.67%42.67% 0.00 pp
FII ———————— —
DII ———————— —
Mutual funds (within DII) ———————— —
Public (non-institutional) ———————— —

Public (non-institutional) = SEBI's Public total minus FII minus DII, shown only where all three were filed. A dash means that holder category filed nothing for that quarter. Holder counts are as filed (entities, not schemes).

Shareholding Pattern (latest quarter)

Category% holdingShareholders
Grand Total 100.0000 7326
(B) Public 100.0000 7326
(A) Promoter & Promoter Group 0.0000 0
(C1) Shares underlying DRs 0.0000 0
(C) Non Promoter-Non Public 0.0000 0
(C2) Shares held by Employee Trust 0.0000 0

Named Shareholders

Data unavailable.

Related